Damian Kettlewell
Algemeen Directeur bij Bliss Co. Holdings Ltd.
Profiel
Damian Kettlewell founded Bliss Co. Holdings Ltd.
in 2014 and is currently the Chief Executive Officer.
He also founded BlissCo Cannabis Corp.
in 2013 and held the titles of President, Chief Executive Officer & Director.
Mr. Kettlewell is also the founder of Clairvoyant Therapeutics, Inc. Mr. Kettlewell's former job was as a Director at the Alliance of Beverage Licensees.
Actieve functies van Damian Kettlewell
Bedrijven | Functie | Begin |
---|---|---|
Bliss Co. Holdings Ltd.
Bliss Co. Holdings Ltd. Agricultural Commodities/MillingProcess Industries Bliss Co. Holdings Ltd. processes and distributes recreational cannabis. The company was founded by Damian Kettlewell in 2014 and is headquartered in Vancouver, Canada. | Algemeen Directeur | 01-01-2014 |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Oprichter | - |
Eerdere bekende functies van Damian Kettlewell
Bedrijven | Functie | Einde |
---|---|---|
BLISSCO CANNABIS CORP | Oprichter | - |
Alliance of Beverage Licensees
Alliance of Beverage Licensees Miscellaneous Commercial ServicesCommercial Services Alliance of Beverage Licensees operates as an advocacy organization representing British Columbia’s private liquor industry. The firm's member includes private liquor stores, pubs, bars, nightclubs, hotel liquor licensees, and various agents, industry suppliers, and benefit providers. The company was founded in 1975 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Alliance of Beverage Licensees
Alliance of Beverage Licensees Miscellaneous Commercial ServicesCommercial Services Alliance of Beverage Licensees operates as an advocacy organization representing British Columbia’s private liquor industry. The firm's member includes private liquor stores, pubs, bars, nightclubs, hotel liquor licensees, and various agents, industry suppliers, and benefit providers. The company was founded in 1975 and is headquartered in Vancouver, Canada. | Commercial Services |
Bliss Co. Holdings Ltd.
Bliss Co. Holdings Ltd. Agricultural Commodities/MillingProcess Industries Bliss Co. Holdings Ltd. processes and distributes recreational cannabis. The company was founded by Damian Kettlewell in 2014 and is headquartered in Vancouver, Canada. | Process Industries |
BlissCo Cannabis Corp.
BlissCo Cannabis Corp. Agricultural Commodities/MillingProcess Industries BlissCo Cannabis Corp. engages in cultivating, packaging, processing, and distribution of recreational cannabis. Its products include cannabis oil, CBD Shark Shock, AC/DC, Critical Plus, Cheese Quake, White Widow. The company was founded by Damian Kettlewell in 2013 and is headquartered in Langley, Canada. | Process Industries |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Health Technology |